Justin Zelin

Justin Zelin

Analyst-Equity chez BTIG LLC

Finance
Consumer Services
Health Technology

Profil

Mr. Justin Zelin is a Director at BTIG LLC.
His research coverage focuses on the biotechnology sector, where he specializes in cell therapy, targeted oncology, immunology and auto-immune disease therapeutics.
Prior to BTIG, Mr. Zelin was a Biotech Equity Research Analyst at B.
Riley Securities.
Previously, he held biotech equity research associate roles at Canaccord Genuity and SVB Leerink.
Earlier in his career, Mr. Zelin worked in both academic and industry labs including Agenus, Harvard University and Brigham and Women’s Hospital.
He was also a member of Harvard University’s teaching staff for more than five years.
He earned a master’s degree in biotechnology and a bachelor’s degree in biology from Harvard University.

Postes actifs de Justin Zelin

SociétésPosteDébut
Analyst-Equity 01/01/2021
Tous les postes actifs de Justin Zelin

Anciens postes connus de Justin Zelin

SociétésPosteFin
Analyst-Equity 01/12/2020
Analyst-Equity 01/07/2020
Corporate Officer/Principal 01/04/2019
AGENUS INC. Corporate Officer/Principal 01/09/2016
Voir l'expérience en détail de Justin Zelin

Formation de Justin Zelin

Harvard University Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Justin Zelin

Relations

100 +

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
AGENUS INC.

Health Technology

Entreprise privées4

Finance

Finance

Finance

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Justin Zelin